Identification | Back Directory | [Name]
4-(MORPHOLINOMETHYL)BENZYLAMINE | [CAS]
91271-84-0 | [Synonyms]
AKOS BB-8919 BUTTPARK 98\57-94 AKOS BBS-00002727 TIMTEC-BB SBB011151 4-(MORPHOLINOMETHYL)BENZYLAMINE 4-MORPHOLIN-4-YLMETHYLBENZYLAMINE 4-Morpholino-4ylmethylbenzylamine 4-(4-MORPHOLINYLMETHYL)BENZYLAMINE 4-(Morpholin-4-ylmethyl)benzylamine 97% 4-MORPHOLIN-4-YLMETHYLBENZYLAMINE, 95+% (4-(MorpholinoMethyl)phenyl)MethanaMine 1-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]METHANAMINE {4-[(Morpholin-4-yl)methyl]phenyl}methylamine97% {4-[(Morpholin-4-yl)methyl]phenyl}methylamine 97% 4-[(Morpholin-4-yl)methyl]benzylamine, 4-[4-(Aminomethyl)benzyl]morpholine | [Molecular Formula]
C12H18N2O | [MDL Number]
MFCD05664410 | [MOL File]
91271-84-0.mol | [Molecular Weight]
206.28 |
Chemical Properties | Back Directory | [Melting point ]
54-56°C | [Boiling point ]
324.7±32.0 °C(Predicted) | [density ]
1.103±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C(protect from light) | [pka]
9.18±0.10(Predicted) | [Appearance]
White to off-white Solid | [CAS DataBase Reference]
91271-84-0 |
Hazard Information | Back Directory | [Synthesis]
General procedure for the synthesis of 4-(morpholinomethyl)benzylamine: lithium aluminum hydride (1.13 g, 29.7 mmol) was slowly added to tetrahydrofuran (THF, 50 mL) at 0 °C under nitrogen protection, followed by the dropwise addition of 4-(morpholin-4-ylmethyl)benzyl nitrile (2 g, 9.89 mmol) in THF solution (10 mL). The reaction mixture was stirred at 0 °C for 1 h and then brought to room temperature and continued to stir overnight. Upon completion of the reaction, the mixture was cooled to 0 °C and the reaction was quenched by the slow addition of water (1.15 mL). Next, ether (125 mL) and 3N NaOH aqueous solution (1.15 mL) were added followed by water (3.45 mL) and stirred for 1 hour at room temperature. The solid residue was removed by filtration and the filtrate was concentrated in vacuum to give 4-(morpholinomethyl)benzylamine as a colorless oil (1.87 g, 94% yield). Mass spectrum (APCI+) m/z: 207 ([M + H]+). | [References]
[1] Patent: WO2007/28083, 2007, A2. Location in patent: Page/Page column 91-92 [2] European Journal of Medicinal Chemistry, 2018, vol. 152, p. 31 - 52 |
|
|